Rice Hall James & Associates’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-774,926
Closed -$12.6M 327
2021
Q4
$12.6M Sell
774,926
-48,357
-6% -$708K 0.45% 55
2021
Q3
$12.5M Buy
823,283
+294,311
+56% +$4.6M 0.46% 62
2021
Q2
$9.14M Sell
528,972
-59,279
-10% -$1.09M 0.33% 69
2021
Q1
$11.5M Buy
588,251
+39,603
+7% +$812K 0.37% 63
2020
Q4
$11M Sell
548,648
-11,534
-2% -$236K 0.39% 61
2020
Q3
$10M Buy
560,182
+67,950
+14% +$1.66M 0.4% 60
2020
Q2
$13.3M Buy
492,232
+122,971
+33% +$3.39M 0.57% 52
2020
Q1
$9.13M Buy
+369,261
New +$13.4M 0.51% 58

Rice Hall James & Associates's ZGNX Position: Q1 2022 in Review

Rice Hall James & Associates sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 774,926 shares — an estimated $12.6M sold.

Rice Hall James & Associates first reported a position in ZGNX in Q1 2020 and held it in 8 quarters. The position peaked at $13.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Rice Hall James & Associates reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 774,926 Zogenix, Inc. shares in Q1 2022, an estimated $12.6M.
  • Rice Hall James & Associates first reported a position in Zogenix, Inc. in Q1 2020 and held it in 8 quarters.
  • Rice Hall James & Associates's Zogenix, Inc. position peaked at $13.3M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.